• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的严重程度与高敏 C 反应蛋白值相关,且与健康人群心血管风险增加独立相关。

The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.

机构信息

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Clin Biochem. 2010 Dec;43(18):1399-404. doi: 10.1016/j.clinbiochem.2010.09.003. Epub 2010 Sep 19.

DOI:10.1016/j.clinbiochem.2010.09.003
PMID:20846522
Abstract

OBJECTIVES

We aimed to investigate the correlation between non-alcoholic fatty liver disease (NAFLD) and risk of cardiovascular disease (CVD).

DESIGN AND METHODS

We analyzed 724 subjects without CVD according to presence or absence of NAFLD. Logistic regression model was used to determine if NAFLD was an independent risk factor of CVD.

RESULTS

Subjects with NAFLD had increased percentage of 10-year cardiovascular risk ≧10% compared to those without NAFLD (p<0.001). The severity of NAFLD significantly correlated with increasing Framingham risk score and C-relative protein (CRP) value. After adjusting for conventional CVD risk factors, the presence of NAFLD was an independent predictor for future CVD risk ≧10% [odds ratio: 1.89, p=0.004]. Subgroup analysis showed the predictive value of NAFLD was significant among aged subjects and those with increased baseline hsCRP level.

CONCLUSIONS

NAFLD is independently associated with increased CVD risk, especially among elderly subjects and those with increased CRP level.

摘要

目的

我们旨在研究非酒精性脂肪性肝病(NAFLD)与心血管疾病(CVD)风险之间的相关性。

设计和方法

我们根据是否存在 NAFLD 分析了 724 例无 CVD 的受试者。使用逻辑回归模型确定 NAFLD 是否是 CVD 的独立危险因素。

结果

与无 NAFLD 者相比,存在 NAFLD 的受试者 10 年心血管风险 ≧10%的比例增加(p<0.001)。NAFLD 的严重程度与Framingham 风险评分和 C-反应蛋白(CRP)值的增加显著相关。在校正了传统的 CVD 危险因素后,存在 NAFLD 是未来 CVD 风险 ≧10%的独立预测因子[比值比:1.89,p=0.004]。亚组分析显示,NAFLD 在老年受试者和基线 hsCRP 水平升高的患者中具有显著的预测价值。

结论

NAFLD 与 CVD 风险增加独立相关,尤其是在老年患者和 CRP 水平升高的患者中。

相似文献

1
The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.非酒精性脂肪性肝病的严重程度与高敏 C 反应蛋白值相关,且与健康人群心血管风险增加独立相关。
Clin Biochem. 2010 Dec;43(18):1399-404. doi: 10.1016/j.clinbiochem.2010.09.003. Epub 2010 Sep 19.
2
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的内皮功能障碍与心血管风险概况
Hepatology. 2005 Aug;42(2):473-80. doi: 10.1002/hep.20781.
3
Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.患有非酒精性脂肪性肝病的2型糖尿病患者心血管疾病患病率增加。
Diabet Med. 2006 Apr;23(4):403-9. doi: 10.1111/j.1464-5491.2006.01817.x.
4
Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者高敏C反应蛋白水平与肝脏组织学的关系
J Hepatol. 2006 Dec;45(6):879-81; author reply 881-2. doi: 10.1016/j.jhep.2006.09.005. Epub 2006 Oct 4.
5
Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.非酒精性脂肪性肝病与心血管疾病风险标志物相关。
Obes Rev. 2009 Jul;10(4):412-9. doi: 10.1111/j.1467-789X.2009.00594.x. Epub 2009 Apr 21.
6
Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.非酒精性脂肪性肝病对加速代谢并发症的影响。
J Dig Dis. 2008 May;9(2):63-7. doi: 10.1111/j.1751-2980.2008.00323.x.
7
[Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].[非酒精性脂肪肝、高敏C反应蛋白与胰岛素抵抗]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;33(7):565-70.
8
Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.非酒精性脂肪性肝炎患者血清细胞间黏附分子-1:与酒精性肝炎的比较
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7. doi: 10.1111/j.1530-0277.2006.00292.x.
9
C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.C反应蛋白、胰岛素抵抗与心血管疾病风险:一项基于人群的研究。
Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8. doi: 10.1097/HJR.0b013e328308bb8b.
10
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.非酒精性脂肪性肝病、代谢综合征与心血管疾病风险:情况愈发复杂。
Diabet Med. 2007 Jan;24(1):1-6. doi: 10.1111/j.1464-5491.2007.02025.x.

引用本文的文献

1
Polymorphic and Expressional Analysis of Genes and in Cardiovascular Patients Using Conventional and qPCR Approach.使用传统方法和定量聚合酶链反应方法对心血管疾病患者的基因进行多态性和表达分析。
Int J Hypertens. 2025 Aug 25;2025:7379376. doi: 10.1155/ijhy/7379376. eCollection 2025.
2
Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut-Liver Axis.肠-肝轴中免疫屏障失调相关 ROS 凋亡机制下内毒素对细胞的炎症作用。
Int J Mol Sci. 2024 Feb 20;25(5):2472. doi: 10.3390/ijms25052472.
3
Biomarkers of Hepatic Dysfunction and Cardiovascular Risk.
肝功能障碍和心血管风险的生物标志物。
Curr Cardiol Rep. 2023 Dec;25(12):1783-1795. doi: 10.1007/s11886-023-01993-5. Epub 2023 Nov 16.
4
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease.射血分数降低的心力衰竭合并非酒精性脂肪性肝病患者的治疗方法。
World J Cardiol. 2023 Jul 26;15(7):328-341. doi: 10.4330/wjc.v15.i7.328.
5
Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity.C 反应蛋白与严重肥胖个体非酒精性脂肪性肝病的组织学、弹性成像和超声指数的相关性。
J Health Popul Nutr. 2023 Apr 7;42(1):30. doi: 10.1186/s41043-023-00372-8.
6
Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.膳食干预及其联合干预对非酒精性脂肪性肝病患者炎症标志物的影响:系统评价和荟萃分析。
Adv Nutr. 2023 May;14(3):475-499. doi: 10.1016/j.advnut.2023.01.001. Epub 2023 Feb 1.
7
Association between high-sensitivity-CRP and liver elastography and cardiac ischemic diseases in patients with fatty liver.非酒精性脂肪性肝病患者高敏C反应蛋白与肝脏弹性成像及心脏缺血性疾病的相关性
J Family Med Prim Care. 2022 Sep;11(9):5495-5499. doi: 10.4103/jfmpc.jfmpc_2223_21. Epub 2022 Oct 14.
8
Intestinal Barrier and Permeability in Health, Obesity and NAFLD.健康、肥胖和非酒精性脂肪性肝病中的肠道屏障与通透性
Biomedicines. 2021 Dec 31;10(1):83. doi: 10.3390/biomedicines10010083.
9
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.炎症标志物在脂肪性肝病诊断或风险预测中的应用:争议与机遇
Front Immunol. 2021 Feb 9;11:634409. doi: 10.3389/fimmu.2020.634409. eCollection 2020.
10
Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter.非酒精性脂肪性肝病与心血管疾病:关键中的关键。
Can J Gastroenterol Hepatol. 2021 Jan 12;2021:6696857. doi: 10.1155/2021/6696857. eCollection 2021.